Immunophenotypic profile of tumor infiltrating lymphocytes in medullary carcinoma of the breast

Medullary carcinoma (MC) of the breast is considered to carry a more favorable prognosis than other subtypes of infiltrating ductal carcinoma. This is a biological paradox because its clinical behavior contrasts with its anaplastic morphology. MC is characterized by a dense lymphocytic infiltrate. In this study, we determined the immunological profile of tumor infiltrating lymphocytes (TILs) in MC by CD20 (L26), CD8, and CD45RO (UCHL 1) immunostaining on paraffin-embedded sections. We examined 14 cases of typical MC (TMC), 15 cases of atypical MC (AMC) classified according to Ridolfi criteria (1977) and 19 cases of poorly differentiated infiltrating ductal carcinoma (PDC-NOS). TILs were quantified separately into cells infiltrating tumor nests (intraepithelial) and cells infiltrating tumor stroma (stromal). The number of CD8 positive and CD20 positive cells infiltrating tumor nests and tumor stroma were significantly increased in TMC and AMC as opposed to the PDC-NOS group. There was a loss in the number of CD45RO positive cells, both intraepithelial and stromal, in TMC and AMC as opposed to the PDC-NOS group. We conclude that MC tumor lymphocytic infiltrate demonstrates a mixed-T cytotoxic (CD8+) and B cell (CD20+)-immunophenotypic profile. This might in part explain the improved clinical outcome of the disease.

[1] Simpson J. F.,P age D. L.: "Prognostic value of histopathology of the breast". Semin. Oneal., 1992, 19, 254.

[2] Page D. L., Anderson T. J., Sakamoto G.: "Infiltrating carcmoma: major histological types". In Page D. L., Anderson T. J. (eds.): Diagnostic Histopathology of the Breast, Edinburgh, Churchill Livingstone, 1987.

[3] Rapin V.,C ontessoG .,M ouriesse H. et al.: "Medullary breast carcinoma: a reevaluation of 95 cases of breast cancer with inflammatory stroma". Cancer, 1988, 61, 2503.

[4] Wargotz E. S., Silverberg S. G.: "Medullary carcinoma of the breast: a clinicopathologic study with appraisal of current diagnostic criteria". Hum. Pathol., 1988, 19, 1340.

[5] Ridolfi R. L.,R osen P. P.,P ort A. et al.: "Medullary carcinoma of the breast: a clinicopathologic study with IO year follow-up" Cancer, 1977, 40, 1365.

[6] Fisher E. R., Kenny J.P., Sass R. et al.: "Medullary cancer of the breast revisited". Breas t Cancer Res. Treat., 1990, 16, 215.

[7] Anderson T. J., Lamb J., Donnan P. et al.: "Comparative pathology of breast cancer in a randomized trial of screening". Br. J. Cancer, 1991, 64, 108.

[8] Fisher E. R.,G regorio R. M., Fisher B.: "The pathology of invasive breast cancer". Cancer, 1975, 36, 1.

[9] Kotlan B.,G ruel N.,Z afrani B.,F urediG .,F oldi J.,P etranyiG .G. et al.: "Immunoglobulin variable regions usage by B-lymphocytes infiltrating a human breast medullary carcinoma". lm m unl. Let t., 1999, 65 (3), 143.

[10] Yakirevich E., Izhak 0. B., Rennert G., Kovacs Z. G., Resnick M. B.: "Cytotoxic phenotype of tumor infiltrating lymphocytes in medullary carcinoma of the breast". Mod. Pathol., 1999, 12 (11), 1050.

[11] Hansen M. H., Nielsen H., Ditzel H. J.: "The tumor-infiltrating B cells response in medullary breast cancer is oligoclonal and directed against the autoantigen actin exposed on the surface of apoptotic cancer cells". Proc. Nat l. Acad. Sci., 2001, 23, 98(22), 12659.

[12] Hudson J. M.,C astilleja A.,M urray J. L., Honda T., Kudelka A., Singletary E. et al.: "Growth and antigen recognition of tumorinfiltrating lymphocytes from human breast cancer". J. Interferon Cytokine Res., 1998, 18 (7), 529.

[13] ShimokawaraI .,I mamura M.,Y amanaka N., Ishii Y.,K ikuchi K.: "Identification of lymphocyte subpopulations in human breast cancer tissue and its significance: an immunoperoxidase study with anti-human T- and B-cell sera". Cancer, 1982, 49 (7), 1456.

[14] Kontani K., Sawai S., Hanaoka J., Tezuka N., Inoue S., Fujino S.: "Involvement of granzyme B and perforin in suppressing nodal metastasis of cancer cells in breast and lung cancers". Eur. J. Surg. Oncol., 2001, 27 (2), 180.

[15] Toso J. F., Oei C., Oshidari F., Tartaglia J., Paoletti E., Lyerly H. K. et al.: "MAGE-I-specific precursor cytotoxic T-lymphocytes present among tumor-infiltrating lymphocytes from a patient with breast cancer characterization and antigen-specific activation". Cancer Res., 1996, 56 (1), 16.

[16] Grekou A. N., Toliou T., Stravoravdi P., Patkiouta F., Tsoukalas T., Pinakidis M., Keramidas G.: "Correlation of apoptosis with the distribution and composition of lymphocytic infiltrate in human breast carcinomas". Anticancer Res., 1996, 16 (6C), 3991.

[17] Donnerstag B., Schroder W., Stegmuller M., Ruenauver A., Lissner R., Bender H. G.: "Functional analysis of tumor-associated lymphocytes from gynecological tumors". Clin. Exp. Obstet. Gynecol., 1993, 20 (3), 137.

[18] Marrogi A. l, Munshi A., Merogi A. J., Ohadike Y, El-Habashi A., Marrogi 0. L, F reeman S. M.: "Study of tumor infiltrating lymphocytes and transforming growth factor-beta as prognostic factors in breast carcinoma". Int. J. Cancer, 1997, 74 (5), 492.